239 related articles for article (PubMed ID: 21321991)
1. Wnt10b activates the Wnt, notch, and NFκB pathways in U2OS osteosarcoma cells.
Mödder UI; Oursler MJ; Khosla S; Monroe DG
J Cell Biochem; 2011 May; 112(5):1392-402. PubMed ID: 21321991
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of the WNT5A Alternative Promoter B Is Associated with DNA Methylation and Histone Modification in Osteosarcoma Cell Lines U2OS and SaOS-2.
Vaidya H; Rumph C; Katula KS
PLoS One; 2016; 11(3):e0151392. PubMed ID: 26978652
[TBL] [Abstract][Full Text] [Related]
3. HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.
Dailey DD; Anfinsen KP; Pfaff LE; Ehrhart EJ; Charles JB; Bønsdorff TB; Thamm DH; Powers BE; Jonasdottir TJ; Duval DL
BMC Vet Res; 2013 Jul; 9():130. PubMed ID: 23816051
[TBL] [Abstract][Full Text] [Related]
4. High Wnt signaling represses the proapoptotic proteoglycan syndecan-2 in osteosarcoma cells.
Dieudonné FX; Marion A; Haÿ E; Marie PJ; Modrowski D
Cancer Res; 2010 Jul; 70(13):5399-408. PubMed ID: 20530678
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy.
Ma Y; Ren Y; Han EQ; Li H; Chen D; Jacobs JJ; Gitelis S; O'Keefe RJ; Konttinen YT; Yin G; Li TF
Biochem Biophys Res Commun; 2013 Feb; 431(2):274-9. PubMed ID: 23291185
[TBL] [Abstract][Full Text] [Related]
6. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.
Enomoto M; Hayakawa S; Itsukushima S; Ren DY; Matsuo M; Tamada K; Oneyama C; Okada M; Takumi T; Nishita M; Minami Y
Oncogene; 2009 Sep; 28(36):3197-208. PubMed ID: 19561643
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNAs in osteosarcoma via various signaling pathways.
Han J; Shen X
J Clin Lab Anal; 2020 Jun; 34(6):e23317. PubMed ID: 32249459
[TBL] [Abstract][Full Text] [Related]
8. FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.
Brun J; Dieudonné FX; Marty C; Müller J; Schüle R; Patiño-García A; Lecanda F; Fromigué O; Marie PJ
PLoS One; 2013; 8(1):e55034. PubMed ID: 23383046
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin Inhibits Proliferation of Osteosarcoma Cells Through Upregulation of the Notch Signaling Pathway.
Ji P; Yu L; Guo WC; Mei HJ; Wang XJ; Chen H; Fang S; Yang J
Oncol Res; 2014; 22(4):185-191. PubMed ID: 26351207
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of microRNA-340 promotes osteosarcoma cell apoptosis while suppressing proliferation, migration, and invasion by inactivating the CTNNB1-mediated Notch signaling pathway.
Pan BL; Wu L; Pan L; Yang YX; Li HH; Dai YJ; He ZQ; Tan L; Huang YG; Tong ZW; Liao JL
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29769415
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-199b-5p is involved in the Notch signaling pathway in osteosarcoma.
Won KY; Kim YW; Kim HS; Lee SK; Jung WW; Park YK
Hum Pathol; 2013 Aug; 44(8):1648-55. PubMed ID: 23574781
[TBL] [Abstract][Full Text] [Related]
12. Developmental pathways hijacked by osteosarcoma.
Mortus JR; Zhang Y; Hughes DP
Adv Exp Med Biol; 2014; 804():93-118. PubMed ID: 24924170
[TBL] [Abstract][Full Text] [Related]
13. Study of the aqueous extract of Aloe vera and its two active components on the Wnt/β-catenin and Notch signaling pathways in colorectal cancer cells.
Peng C; Zhang W; Dai C; Li W; Shen X; Yuan Y; Yan L; Zhang W; Yao M
J Ethnopharmacol; 2019 Oct; 243():112092. PubMed ID: 31319122
[TBL] [Abstract][Full Text] [Related]
14. Recognizing genes differentially regulated in vitro by the multiple endocrine neoplasia type 1 (MEN1) gene, using RNA interference and oligonucleotide microarrays.
Stålberg P; Santesson M; Ekeblad S; Lejonklou MH; Skogseid B
Surgery; 2006 Dec; 140(6):921-9; discussion 929-31. PubMed ID: 17188139
[TBL] [Abstract][Full Text] [Related]
15. Wnt3A activates canonical Wnt signalling in acute lymphoblastic leukaemia (ALL) cells and inhibits the proliferation of B-ALL cell lines.
Nygren MK; Døsen G; Hystad ME; Stubberud H; Funderud S; Rian E
Br J Haematol; 2007 Feb; 136(3):400-13. PubMed ID: 17156404
[TBL] [Abstract][Full Text] [Related]
16. Wnt signaling in osteosarcoma.
Lin CH; Ji T; Chen CF; Hoang BH
Adv Exp Med Biol; 2014; 804():33-45. PubMed ID: 24924167
[TBL] [Abstract][Full Text] [Related]
17. Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway.
Jiang Z; Jiang C; Fang J
Biochem Biophys Res Commun; 2018 Jan; 495(1):238-245. PubMed ID: 29108989
[TBL] [Abstract][Full Text] [Related]
18. Wnt/β-Catenin Signaling Activates Expression of the Bone-Related Transcription Factor RUNX2 in Select Human Osteosarcoma Cell Types.
Vega OA; Lucero CMJ; Araya HF; Jerez S; Tapia JC; Antonelli M; Salazar-Onfray F; Las Heras F; Thaler R; Riester SM; Stein GS; van Wijnen AJ; Galindo MA
J Cell Biochem; 2017 Nov; 118(11):3662-3674. PubMed ID: 28370561
[TBL] [Abstract][Full Text] [Related]
19. Nasopharyngeal carcinoma‑associated gene 6 inhibits cell viability, migration, invasion and induces apoptosis in osteosarcoma cells by inactivating the Wnt/β‑catenin signaling pathway.
Liu L; Wang R; Zhang Z; Wang X
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300077
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of miR‑214 promotes the progression of human osteosarcoma by regulating the Wnt/β‑catenin signaling pathway.
Zhu XB; Zhang ZC; Han GS; Han JZ; Qiu DP
Mol Med Rep; 2017 Apr; 15(4):1884-1892. PubMed ID: 28260089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
